| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/22/2008 | US20080119434 Sir2a-based therapeutic and prophylactic methods |
| 05/22/2008 | US20080119429 Methods and means for increasing resistance to cell damage |
| 05/22/2008 | US20080119423 isolated antisense oligonucleotide hybrids for treating pain in a mammal; biodrugs |
| 05/22/2008 | US20080119400 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H |
| 05/22/2008 | US20080119398 Modified Thioredoxin |
| 05/22/2008 | US20080119387 Contacting small molecule or polypeptide with a cell, cell extract, or purified cell components containing L41 and ribosomes, detecting whether the test composition inhibits the interaction of L41 with the ribosomes; anddetermining whether the test composition inhibits peptidyl transferase activity |
| 05/22/2008 | US20080118981 Methods for producing transgenic plants |
| 05/22/2008 | US20080118980 Estrogen Enhancing Differentiation of Human Mesenchymal Stromal Cells and Adipose-derived Stromal Cells |
| 05/22/2008 | US20080118979 Methods of regulating expression of genes or of gene products using substituted tetracycline compounds |
| 05/22/2008 | US20080118978 Using chimeric immunoglobulin specific to CD10 in treatment and prevention of cell proliferative disorders; inducing antibody-dependent cell-mediated cytotoxicity |
| 05/22/2008 | US20080118977 Propagating CD34 cells in presence colony stimulating factor with subsequent injection of culture into patient to enhance heart function after cardiovascular event |
| 05/22/2008 | US20080118976 Carrier for undifferentiated cell culture and subculture method thereof |
| 05/22/2008 | US20080118968 Using expressed sequences tags isolated from red alga as reporter tool in vectors; genomics; identifying plant defense genes |
| 05/22/2008 | US20080118951 Nogo receptor homologues and their use |
| 05/22/2008 | US20080118949 Intracellular Production Of A Nuclease |
| 05/22/2008 | US20080118948 Generating vector comprising regulatory sequences associated with protein translation elongation factor TU (P EF-TU); improving exogenous gene expression |
| 05/22/2008 | US20080118941 For imaging live cells and subcellular trafficking processes; electroporation |
| 05/22/2008 | US20080118937 Monoclonal antibody for detecting staphylococcal infection |
| 05/22/2008 | US20080118935 Using filamin A concentration as diagnostic indicator of celll proliferative disorders |
| 05/22/2008 | US20080118929 Using concentration of transcription intermediary factor-1 beta (TIF1-beta) as diagnostic/prognostic indicator oc cell proliferative disorders |
| 05/22/2008 | US20080118922 Flap Endonuclease Mutants |
| 05/22/2008 | US20080118913 Genetic manipulation of brain serotonin using the pet-1 transcriptional control region |
| 05/22/2008 | US20080118909 Methods and kits for isolating sperm cells |
| 05/22/2008 | US20080118623 a nucleotide sequence encoding a polypeptide having delta-8 desaturase activity; use of this desaturase in making long-chain polyunsaturated fatty acids (PUFAs). |
| 05/22/2008 | US20080118617 promoters isolated from Glycine max and Arabidopsis thaliana that are useful for regulating gene expression of heterologous polynucleotide molecules in plants; useful for production of transgenic plants with desired seed traits |
| 05/22/2008 | US20080118569 Biocompatible, hydrophilic, non-toxic microspheres associated with stem cells and a biocompatible carrier and are not capable of being displaced, or eliminated by the lymphatic system; tissue-targeted therapy, tissue repair |
| 05/22/2008 | US20080118528 Expressing a construct comprising the prM and E genes in a baculoviral expression cassette and cloned under the control of a promoter in insect cells; culturing; separation by lysis; diagnostic and therapeutic vaccines; vaccination |
| 05/22/2008 | US20080118526 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 05/22/2008 | US20080118525 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 05/22/2008 | US20080118521 Using short intefering nucleotide sequences specific to helix-loop-helix protein (HEY-1) to treat and prevent osteoprosis and bone disorders; gene expression inhibition; antisense agents |
| 05/22/2008 | US20080118520 Variable heavy chains; immunoglobulins; neurodegenerative diseases |
| 05/22/2008 | US20080118515 Regulatory T-Cells Containing Galectins for the Therapy and Diagnosis of Diseases |
| 05/22/2008 | US20080118513 Treatment of immune disorders with antibodies to costimulating polypeptide of T cells |
| 05/22/2008 | US20080118512 Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK |
| 05/22/2008 | US20080118511 PD-L2 Molecules: Novel PD-1 Ligands and Uses Therefor |
| 05/22/2008 | US20080118510 Vegf-related protein |
| 05/22/2008 | US20080118508 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
| 05/22/2008 | US20080118506 Humanized Anti-Factor D Antibodies and Uses Thereof |
| 05/22/2008 | US20080118504 Pattern recogniton receptor for use in identifying modulator for treatment and prevention of sepsis, graft vs host, autoimmune, inflammatory and respiratory disorders |
| 05/22/2008 | US20080118495 Using avian cells as screening tools in monitoring and/or identifying viricidal agents |
| 05/22/2008 | US20080118494 Transgenic lymphocyte for use as model to screen viral activating and inhibitory agenys; viricides and vaccines |
| 05/22/2008 | US20080118493 Elevated Hedgehog Pathway Activity In Digestive System Tumors, And Methods Of Treating Digestive Sytem Tumors Having Elevated Hedgehog Pathway Activity |
| 05/22/2008 | US20080118491 Xylanase gene sequences from the genomic DNA of unpurified rumen microorganisms |
| 05/22/2008 | US20080118487 Cell growth factor polypeptide for use in enhancing muscle growth and treatment muscular disorders |
| 05/22/2008 | US20080118486 Using stem cell mixture comprising cluster of differentiation-34 proteins to generate cardiac tissue for treatment of myocardial infarction; tissue engineering; regenerative medicine |
| 05/22/2008 | US20080118481 Mononuclear phagocytes in therapeutic drug delivery |
| 05/22/2008 | US20080118480 Methods and Compositions for Directing Migration of Neural Progenitor Cells |
| 05/22/2008 | US20080118479 Cell Lines |
| 05/22/2008 | US20080118477 Umbilical cord mesenchymal stem cells support cord blood hematopoiesis |
| 05/22/2008 | US20080118475 Plurality of live cells obtained from mammalian tissue or organ for use as tools in monitoring efficacy od compounds for treatment of neurodegenerative diseases |
| 05/22/2008 | US20080118474 Biological scaffold comprising periodontal ligament fibroblasts and at least one type of cementoblasts, osteoblasts, gingival fibroblasts and/endothelial cells for use in treatment of periodontitis, severe peridontitis, gingival recession |
| 05/22/2008 | US20080118438 Loss of function mutations in calcium channel polypeptides associated with sudden cardiac death |
| 05/22/2008 | US20080115549 Novel aqueous composition and use of the same |
| 05/22/2008 | CA2702370A1 Compositions and methods for immunotherapy |
| 05/22/2008 | CA2669969A1 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb3, hsdl2 and/or ldb2 |
| 05/22/2008 | CA2669891A1 Expression system of nell peptide |
| 05/22/2008 | CA2669641A1 Thrombin mutant |
| 05/22/2008 | CA2669589A1 In vitro expansion of postpartum-derived cells using microcarriers |
| 05/22/2008 | CA2668503A1 Cancerous disease modifying antibodies 180706-01 |
| 05/22/2008 | CA2668496A1 Cancerous disease modifying antibodies |
| 05/22/2008 | CA2668484A1 Cancerous disease modifying antibodies 180706-02 |
| 05/22/2008 | CA2665475A1 Methods and compositions useful for diabetic wound healing |
| 05/22/2008 | CA2654000A1 Anti-dll4 antibodies and methods using same |
| 05/22/2008 | CA2568663A1 Methods and materials for culturing murine embryonic stem cells |
| 05/21/2008 | EP1923466A2 Vectors encoding recombinant AAV genomes |
| 05/21/2008 | EP1923465A1 Inhibitor protein for the WNT signal pathway |
| 05/21/2008 | EP1922410A2 Gene disruptions, compositions and methods relating thereto |
| 05/21/2008 | EP1922084A2 Chikungunya virus infectious clones and uses thereof |
| 05/21/2008 | EP1805297A4 The use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division |
| 05/21/2008 | EP1753860A4 Intervertebral disc repair, methods and devices therefor |
| 05/21/2008 | EP1752163A4 Agent for actively restoring structure and functions of damaged tissues and organs |
| 05/21/2008 | EP1727552B1 Tissue repair with multipotent cells |
| 05/21/2008 | EP1725653B1 Methods for purification of cells based on product secretion |
| 05/21/2008 | EP1718734B8 Methods for genetic diversification in gene conversion active cells |
| 05/21/2008 | EP1699523A4 Creation of a biological atrioventricular bypass to compensate for atrioventricular block |
| 05/21/2008 | EP1366158B1 Trp8 markers for cancer |
| 05/21/2008 | EP1362115B1 Multi-sample fermentor and method of using same |
| 05/21/2008 | EP1319069B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 05/21/2008 | EP1317526B1 Bio-reactor device |
| 05/21/2008 | EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/21/2008 | EP1227837B1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/21/2008 | EP1208200B1 Transgenic animal model for neurodegenerative diseases |
| 05/21/2008 | EP1054687B1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 05/21/2008 | EP1003545B1 Heparin-binding growth factor (hbgf) polypeptides |
| 05/21/2008 | EP0960209B1 Editing-based selectable plastid marker genes |
| 05/21/2008 | EP0924986B1 Antioxidant derived from lentil and its preparation and uses |
| 05/21/2008 | EP0904395B1 Herpes simplex virus strains |
| 05/21/2008 | EP0850304B1 Cerebellum-derived growth factors, and uses related thereto |
| 05/21/2008 | EP0807166B1 A method of preparing an undifferentiated cell |
| 05/21/2008 | CN101184776A Novel anti-plgf antibody |
| 05/21/2008 | CN101182547A Composite skin taking hair follicle stem cells as seed cell and construction method thereof |
| 05/21/2008 | CN101182542A Method for genetic transforming scutellaria viscidula to obtain hairy roots producing baicalin by agrobacteriitm rhizogenes |
| 05/21/2008 | CN101182506A Fixation fluid for saving cast-off cells and manufacturing method of cell shallow layer smear |
| 05/21/2008 | CN101182493A Transgenic mesenchyma stem cell for curing radiation enteritis and method of producing the same |
| 05/21/2008 | CN101182492A Vitro model for dynamic modeling human glioma cell displace |
| 05/21/2008 | CN101182491A Vitro model capable of Dynamic modeling human cancer of liver displace |
| 05/21/2008 | CN101182490A Culture medium used for Vero cell and cultivation method thereof |
| 05/21/2008 | CN101182489A Method for cloning animal somatic cell |
| 05/21/2008 | CN101182488A New use of mesenchyma stem cell |
| 05/21/2008 | CN101182487A Insect epidermis cell line as well as construction method and use thereof |